0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Q-PCR and D-PCR Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-39Q17030
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Q PCR and D PCR Devices Market Research Report 2024
BUY CHAPTERS

Global Q-PCR and D-PCR Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-39Q17030
Report
November 2025
Pages:177
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Q-PCR and D-PCR Devices Market

The global Q-PCR and D-PCR Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Q-PCR and D-PCR are variants of two common polymerase chain reaction (PCR) techniques.Q-PCR and D-PCR devices typically include components such as PCR instruments, fluorescent probes, PCR kits, and digital PCR chips to perform PCR amplification and fluorescence signal detection.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Q-PCR and D-PCR Devices leading manufacturers including F. Hoffmann-La Roche, Thermo Fisher Scientific, Bio-Rad, QIAGEN, Takara Bio, Agilent Technologies, bioMérieux, Danaher, Abbott, Merck KGaA, etc., dominate supply; the top five capture approximately % of global revenue, with F. Hoffmann-La Roche leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Q-PCR and D-PCR Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Q-PCR and D-PCR Devices Market Report

Report Metric Details
Report Name Q-PCR and D-PCR Devices Market
Segment by Type
  • Quantitative PCR
  • Digital PCR
Segment by Application
  • Hospital
  • Diagnostic Centre
  • Research Laboratory
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company F. Hoffmann-La Roche, Thermo Fisher Scientific, Bio-Rad, QIAGEN, Takara Bio, Agilent Technologies, bioMérieux, Danaher, Abbott, Merck KGaA, BD, Promega Corporation, Eppendorf, Analytik Jena, Meridian Bioscience, Enzo Life Sciences, Cole-Parmer Instrument, Bioneer Corporation, ELITechGroup, Quantabio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Q-PCR and D-PCR Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Q-PCR and D-PCR Devices Market report?

Ans: The main players in the Q-PCR and D-PCR Devices Market are F. Hoffmann-La Roche, Thermo Fisher Scientific, Bio-Rad, QIAGEN, Takara Bio, Agilent Technologies, bioMérieux, Danaher, Abbott, Merck KGaA, BD, Promega Corporation, Eppendorf, Analytik Jena, Meridian Bioscience, Enzo Life Sciences, Cole-Parmer Instrument, Bioneer Corporation, ELITechGroup, Quantabio

What are the Application segmentation covered in the Q-PCR and D-PCR Devices Market report?

Ans: The Applications covered in the Q-PCR and D-PCR Devices Market report are Hospital, Diagnostic Centre, Research Laboratory, Other

What are the Type segmentation covered in the Q-PCR and D-PCR Devices Market report?

Ans: The Types covered in the Q-PCR and D-PCR Devices Market report are Quantitative PCR, Digital PCR

1 Study Coverage
1.1 Introduction to Q-PCR and D-PCR Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Q-PCR and D-PCR Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Quantitative PCR
1.2.3 Digital PCR
1.3 Market Segmentation by Application
1.3.1 Global Q-PCR and D-PCR Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Diagnostic Centre
1.3.4 Research Laboratory
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Q-PCR and D-PCR Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Q-PCR and D-PCR Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Q-PCR and D-PCR Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Q-PCR and D-PCR Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Q-PCR and D-PCR Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Q-PCR and D-PCR Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Quantitative PCR Market Size by Manufacturers
3.5.2 Digital PCR Market Size by Manufacturers
3.6 Global Q-PCR and D-PCR Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Q-PCR and D-PCR Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Q-PCR and D-PCR Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Q-PCR and D-PCR Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Q-PCR and D-PCR Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Q-PCR and D-PCR Devices Sales and Revenue by Type (2020-2031)
6.4 North America Q-PCR and D-PCR Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Q-PCR and D-PCR Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Q-PCR and D-PCR Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Q-PCR and D-PCR Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Q-PCR and D-PCR Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Q-PCR and D-PCR Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Q-PCR and D-PCR Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Q-PCR and D-PCR Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Q-PCR and D-PCR Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Q-PCR and D-PCR Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Q-PCR and D-PCR Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Q-PCR and D-PCR Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Q-PCR and D-PCR Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Q-PCR and D-PCR Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.1.4 F. Hoffmann-La Roche Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 F. Hoffmann-La Roche Q-PCR and D-PCR Devices Sales by Product in 2024
11.1.6 F. Hoffmann-La Roche Q-PCR and D-PCR Devices Sales by Application in 2024
11.1.7 F. Hoffmann-La Roche Q-PCR and D-PCR Devices Sales by Geographic Area in 2024
11.1.8 F. Hoffmann-La Roche Q-PCR and D-PCR Devices SWOT Analysis
11.1.9 F. Hoffmann-La Roche Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.2.4 Thermo Fisher Scientific Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific Q-PCR and D-PCR Devices Sales by Product in 2024
11.2.6 Thermo Fisher Scientific Q-PCR and D-PCR Devices Sales by Application in 2024
11.2.7 Thermo Fisher Scientific Q-PCR and D-PCR Devices Sales by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific Q-PCR and D-PCR Devices SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Corporation Information
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.3.4 Bio-Rad Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bio-Rad Q-PCR and D-PCR Devices Sales by Product in 2024
11.3.6 Bio-Rad Q-PCR and D-PCR Devices Sales by Application in 2024
11.3.7 Bio-Rad Q-PCR and D-PCR Devices Sales by Geographic Area in 2024
11.3.8 Bio-Rad Q-PCR and D-PCR Devices SWOT Analysis
11.3.9 Bio-Rad Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Corporation Information
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.4.4 QIAGEN Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 QIAGEN Q-PCR and D-PCR Devices Sales by Product in 2024
11.4.6 QIAGEN Q-PCR and D-PCR Devices Sales by Application in 2024
11.4.7 QIAGEN Q-PCR and D-PCR Devices Sales by Geographic Area in 2024
11.4.8 QIAGEN Q-PCR and D-PCR Devices SWOT Analysis
11.4.9 QIAGEN Recent Developments
11.5 Takara Bio
11.5.1 Takara Bio Corporation Information
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.5.4 Takara Bio Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Takara Bio Q-PCR and D-PCR Devices Sales by Product in 2024
11.5.6 Takara Bio Q-PCR and D-PCR Devices Sales by Application in 2024
11.5.7 Takara Bio Q-PCR and D-PCR Devices Sales by Geographic Area in 2024
11.5.8 Takara Bio Q-PCR and D-PCR Devices SWOT Analysis
11.5.9 Takara Bio Recent Developments
11.6 Agilent Technologies
11.6.1 Agilent Technologies Corporation Information
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.6.4 Agilent Technologies Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Agilent Technologies Recent Developments
11.7 bioMérieux
11.7.1 bioMérieux Corporation Information
11.7.2 bioMérieux Business Overview
11.7.3 bioMérieux Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.7.4 bioMérieux Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 bioMérieux Recent Developments
11.8 Danaher
11.8.1 Danaher Corporation Information
11.8.2 Danaher Business Overview
11.8.3 Danaher Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.8.4 Danaher Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Danaher Recent Developments
11.9 Abbott
11.9.1 Abbott Corporation Information
11.9.2 Abbott Business Overview
11.9.3 Abbott Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.9.4 Abbott Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Abbott Recent Developments
11.10 Merck KGaA
11.10.1 Merck KGaA Corporation Information
11.10.2 Merck KGaA Business Overview
11.10.3 Merck KGaA Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.10.4 Merck KGaA Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Merck KGaA Recent Developments
11.11 BD
11.11.1 BD Corporation Information
11.11.2 BD Business Overview
11.11.3 BD Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.11.4 BD Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 BD Recent Developments
11.12 Promega Corporation
11.12.1 Promega Corporation Corporation Information
11.12.2 Promega Corporation Business Overview
11.12.3 Promega Corporation Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.12.4 Promega Corporation Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Promega Corporation Recent Developments
11.13 Eppendorf
11.13.1 Eppendorf Corporation Information
11.13.2 Eppendorf Business Overview
11.13.3 Eppendorf Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.13.4 Eppendorf Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Eppendorf Recent Developments
11.14 Analytik Jena
11.14.1 Analytik Jena Corporation Information
11.14.2 Analytik Jena Business Overview
11.14.3 Analytik Jena Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.14.4 Analytik Jena Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Analytik Jena Recent Developments
11.15 Meridian Bioscience
11.15.1 Meridian Bioscience Corporation Information
11.15.2 Meridian Bioscience Business Overview
11.15.3 Meridian Bioscience Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.15.4 Meridian Bioscience Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Meridian Bioscience Recent Developments
11.16 Enzo Life Sciences
11.16.1 Enzo Life Sciences Corporation Information
11.16.2 Enzo Life Sciences Business Overview
11.16.3 Enzo Life Sciences Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.16.4 Enzo Life Sciences Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Enzo Life Sciences Recent Developments
11.17 Cole-Parmer Instrument
11.17.1 Cole-Parmer Instrument Corporation Information
11.17.2 Cole-Parmer Instrument Business Overview
11.17.3 Cole-Parmer Instrument Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.17.4 Cole-Parmer Instrument Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Cole-Parmer Instrument Recent Developments
11.18 Bioneer Corporation
11.18.1 Bioneer Corporation Corporation Information
11.18.2 Bioneer Corporation Business Overview
11.18.3 Bioneer Corporation Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.18.4 Bioneer Corporation Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Bioneer Corporation Recent Developments
11.19 ELITechGroup
11.19.1 ELITechGroup Corporation Information
11.19.2 ELITechGroup Business Overview
11.19.3 ELITechGroup Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.19.4 ELITechGroup Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 ELITechGroup Recent Developments
11.20 Quantabio
11.20.1 Quantabio Corporation Information
11.20.2 Quantabio Business Overview
11.20.3 Quantabio Q-PCR and D-PCR Devices Product Models, Descriptions and Specifications
11.20.4 Quantabio Q-PCR and D-PCR Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Quantabio Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Q-PCR and D-PCR Devices Industry Chain
12.2 Q-PCR and D-PCR Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Q-PCR and D-PCR Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Q-PCR and D-PCR Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Q-PCR and D-PCR Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Q-PCR and D-PCR Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Q-PCR and D-PCR Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Q-PCR and D-PCR Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Q-PCR and D-PCR Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Q-PCR and D-PCR Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Q-PCR and D-PCR Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Q-PCR and D-PCR Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Q-PCR and D-PCR Devices Sales by Region (2020-2025) & (K Units)
 Table 8. Global Q-PCR and D-PCR Devices Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Q-PCR and D-PCR Devices Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Q-PCR and D-PCR Devices Sales Share by Manufacturers (2020-2025)
 Table 12. Global Q-PCR and D-PCR Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Q-PCR and D-PCR Devices Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Q-PCR and D-PCR Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Q-PCR and D-PCR Devices as of 2024)
 Table 16. Global Q-PCR and D-PCR Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Q-PCR and D-PCR Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Q-PCR and D-PCR Devices Manufacturing Base and Headquarters
 Table 19. Global Q-PCR and D-PCR Devices Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Q-PCR and D-PCR Devices Sales by Type (2020-2025) & (K Units)
 Table 23. Global Q-PCR and D-PCR Devices Sales by Type (2026-2031) & (K Units)
 Table 24. Global Q-PCR and D-PCR Devices Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Q-PCR and D-PCR Devices Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Q-PCR and D-PCR Devices ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Q-PCR and D-PCR Devices Sales by Application (2020-2025) & (K Units)
 Table 29. Global Q-PCR and D-PCR Devices Sales by Application (2026-2031) & (K Units)
 Table 30. Q-PCR and D-PCR Devices High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Q-PCR and D-PCR Devices Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Q-PCR and D-PCR Devices Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Q-PCR and D-PCR Devices ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Q-PCR and D-PCR Devices Growth Accelerators and Market Barriers
 Table 37. North America Q-PCR and D-PCR Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Q-PCR and D-PCR Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Q-PCR and D-PCR Devices Growth Accelerators and Market Barriers
 Table 40. Europe Q-PCR and D-PCR Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Q-PCR and D-PCR Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Q-PCR and D-PCR Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Q-PCR and D-PCR Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Q-PCR and D-PCR Devices Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Q-PCR and D-PCR Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Q-PCR and D-PCR Devices Investment Opportunities and Key Challenges
 Table 47. Central and South America Q-PCR and D-PCR Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Q-PCR and D-PCR Devices Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Q-PCR and D-PCR Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. F. Hoffmann-La Roche Corporation Information
 Table 51. F. Hoffmann-La Roche Description and Major Businesses
 Table 52. F. Hoffmann-La Roche Product Models, Descriptions and Specifications
 Table 53. F. Hoffmann-La Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. F. Hoffmann-La Roche Sales Value Proportion by Product in 2024
 Table 55. F. Hoffmann-La Roche Sales Value Proportion by Application in 2024
 Table 56. F. Hoffmann-La Roche Sales Value Proportion by Geographic Area in 2024
 Table 57. F. Hoffmann-La Roche Q-PCR and D-PCR Devices SWOT Analysis
 Table 58. F. Hoffmann-La Roche Recent Developments
 Table 59. Thermo Fisher Scientific Corporation Information
 Table 60. Thermo Fisher Scientific Description and Major Businesses
 Table 61. Thermo Fisher Scientific Product Models, Descriptions and Specifications
 Table 62. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
 Table 64. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
 Table 65. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
 Table 66. Thermo Fisher Scientific Q-PCR and D-PCR Devices SWOT Analysis
 Table 67. Thermo Fisher Scientific Recent Developments
 Table 68. Bio-Rad Corporation Information
 Table 69. Bio-Rad Description and Major Businesses
 Table 70. Bio-Rad Product Models, Descriptions and Specifications
 Table 71. Bio-Rad Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Bio-Rad Sales Value Proportion by Product in 2024
 Table 73. Bio-Rad Sales Value Proportion by Application in 2024
 Table 74. Bio-Rad Sales Value Proportion by Geographic Area in 2024
 Table 75. Bio-Rad Q-PCR and D-PCR Devices SWOT Analysis
 Table 76. Bio-Rad Recent Developments
 Table 77. QIAGEN Corporation Information
 Table 78. QIAGEN Description and Major Businesses
 Table 79. QIAGEN Product Models, Descriptions and Specifications
 Table 80. QIAGEN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. QIAGEN Sales Value Proportion by Product in 2024
 Table 82. QIAGEN Sales Value Proportion by Application in 2024
 Table 83. QIAGEN Sales Value Proportion by Geographic Area in 2024
 Table 84. QIAGEN Q-PCR and D-PCR Devices SWOT Analysis
 Table 85. QIAGEN Recent Developments
 Table 86. Takara Bio Corporation Information
 Table 87. Takara Bio Description and Major Businesses
 Table 88. Takara Bio Product Models, Descriptions and Specifications
 Table 89. Takara Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Takara Bio Sales Value Proportion by Product in 2024
 Table 91. Takara Bio Sales Value Proportion by Application in 2024
 Table 92. Takara Bio Sales Value Proportion by Geographic Area in 2024
 Table 93. Takara Bio Q-PCR and D-PCR Devices SWOT Analysis
 Table 94. Takara Bio Recent Developments
 Table 95. Agilent Technologies Corporation Information
 Table 96. Agilent Technologies Description and Major Businesses
 Table 97. Agilent Technologies Product Models, Descriptions and Specifications
 Table 98. Agilent Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Agilent Technologies Recent Developments
 Table 100. bioMérieux Corporation Information
 Table 101. bioMérieux Description and Major Businesses
 Table 102. bioMérieux Product Models, Descriptions and Specifications
 Table 103. bioMérieux Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. bioMérieux Recent Developments
 Table 105. Danaher Corporation Information
 Table 106. Danaher Description and Major Businesses
 Table 107. Danaher Product Models, Descriptions and Specifications
 Table 108. Danaher Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Danaher Recent Developments
 Table 110. Abbott Corporation Information
 Table 111. Abbott Description and Major Businesses
 Table 112. Abbott Product Models, Descriptions and Specifications
 Table 113. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Abbott Recent Developments
 Table 115. Merck KGaA Corporation Information
 Table 116. Merck KGaA Description and Major Businesses
 Table 117. Merck KGaA Product Models, Descriptions and Specifications
 Table 118. Merck KGaA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Merck KGaA Recent Developments
 Table 120. BD Corporation Information
 Table 121. BD Description and Major Businesses
 Table 122. BD Product Models, Descriptions and Specifications
 Table 123. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. BD Recent Developments
 Table 125. Promega Corporation Corporation Information
 Table 126. Promega Corporation Description and Major Businesses
 Table 127. Promega Corporation Product Models, Descriptions and Specifications
 Table 128. Promega Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Promega Corporation Recent Developments
 Table 130. Eppendorf Corporation Information
 Table 131. Eppendorf Description and Major Businesses
 Table 132. Eppendorf Product Models, Descriptions and Specifications
 Table 133. Eppendorf Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Eppendorf Recent Developments
 Table 135. Analytik Jena Corporation Information
 Table 136. Analytik Jena Description and Major Businesses
 Table 137. Analytik Jena Product Models, Descriptions and Specifications
 Table 138. Analytik Jena Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Analytik Jena Recent Developments
 Table 140. Meridian Bioscience Corporation Information
 Table 141. Meridian Bioscience Description and Major Businesses
 Table 142. Meridian Bioscience Product Models, Descriptions and Specifications
 Table 143. Meridian Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Meridian Bioscience Recent Developments
 Table 145. Enzo Life Sciences Corporation Information
 Table 146. Enzo Life Sciences Description and Major Businesses
 Table 147. Enzo Life Sciences Product Models, Descriptions and Specifications
 Table 148. Enzo Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. Enzo Life Sciences Recent Developments
 Table 150. Cole-Parmer Instrument Corporation Information
 Table 151. Cole-Parmer Instrument Description and Major Businesses
 Table 152. Cole-Parmer Instrument Product Models, Descriptions and Specifications
 Table 153. Cole-Parmer Instrument Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. Cole-Parmer Instrument Recent Developments
 Table 155. Bioneer Corporation Corporation Information
 Table 156. Bioneer Corporation Description and Major Businesses
 Table 157. Bioneer Corporation Product Models, Descriptions and Specifications
 Table 158. Bioneer Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 159. Bioneer Corporation Recent Developments
 Table 160. ELITechGroup Corporation Information
 Table 161. ELITechGroup Description and Major Businesses
 Table 162. ELITechGroup Product Models, Descriptions and Specifications
 Table 163. ELITechGroup Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 164. ELITechGroup Recent Developments
 Table 165. Quantabio Corporation Information
 Table 166. Quantabio Description and Major Businesses
 Table 167. Quantabio Product Models, Descriptions and Specifications
 Table 168. Quantabio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 169. Quantabio Recent Developments
 Table 170. Key Raw Materials Distribution
 Table 171. Raw Materials Key Suppliers
 Table 172. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 173. Milestones in Production Technology Evolution
 Table 174. Distributors List
 Table 175. Market Trends and Market Evolution
 Table 176. Market Drivers and Opportunities
 Table 177. Market Challenges, Risks, and Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources


List of Figures
 Figure 1. Q-PCR and D-PCR Devices Product Picture
 Figure 2. Global Q-PCR and D-PCR Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Quantitative PCR Product Picture
 Figure 4. Digital PCR Product Picture
 Figure 5. Global Q-PCR and D-PCR Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Diagnostic Centre
 Figure 8. Research Laboratory
 Figure 9. Other
 Figure 10. Q-PCR and D-PCR Devices Report Years Considered
 Figure 11. Global Q-PCR and D-PCR Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Q-PCR and D-PCR Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Q-PCR and D-PCR Devices Revenue Market Share by Region (2020-2031)
 Figure 15. Global Q-PCR and D-PCR Devices Sales (2020-2031) & (K Units)
 Figure 16. Global Q-PCR and D-PCR Devices Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Q-PCR and D-PCR Devices Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Q-PCR and D-PCR Devices Sales Volume Market Share in 2024
 Figure 19. Global Q-PCR and D-PCR Devices Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Quantitative PCR Revenue Market Share by Manufacturer in 2024
 Figure 22. Digital PCR Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Q-PCR and D-PCR Devices Sales Market Share by Type (2020-2031)
 Figure 24. Global Q-PCR and D-PCR Devices Revenue Market Share by Type (2020-2031)
 Figure 25. Global Q-PCR and D-PCR Devices Sales Market Share by Application (2020-2031)
 Figure 26. Global Q-PCR and D-PCR Devices Revenue Market Share by Application (2020-2031)
 Figure 27. North America Q-PCR and D-PCR Devices Sales YoY (2020-2031) & (K Units)
 Figure 28. North America Q-PCR and D-PCR Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Q-PCR and D-PCR Devices Sales Revenue (US$ Million) in 2024
 Figure 30. North America Q-PCR and D-PCR Devices Sales Volume (K Units) by Type (2020- 2031)
 Figure 31. North America Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Q-PCR and D-PCR Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 33. North America Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Q-PCR and D-PCR Devices Sales YoY (2020-2031) & (K Units)
 Figure 38. Europe Q-PCR and D-PCR Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Q-PCR and D-PCR Devices Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Q-PCR and D-PCR Devices Sales Volume (K Units) by Type (2020-2031)
 Figure 41. Europe Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Q-PCR and D-PCR Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 43. Europe Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 45. France Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Q-PCR and D-PCR Devices Sales YoY (2020-2031) & (K Units)
 Figure 50. Asia-Pacific Q-PCR and D-PCR Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Q-PCR and D-PCR Devices Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Q-PCR and D-PCR Devices Sales Volume (K Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Q-PCR and D-PCR Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 60. India Q-PCR and D-PCR Devices Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Q-PCR and D-PCR Devices Sales YoY (2020-2031) & (K Units)
 Figure 62. Central and South America Q-PCR and D-PCR Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Q-PCR and D-PCR Devices Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Q-PCR and D-PCR Devices Sales Volume (K Units) by Type (2021-2031)
 Figure 65. Central and South America Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Q-PCR and D-PCR Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 67. Central and South America Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Q-PCR and D-PCR Devices Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Q-PCR and D-PCR Devices Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Q-PCR and D-PCR Devices Sales YoY (2020-2031) & (K Units)
 Figure 71. Middle East and Africa Q-PCR and D-PCR Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Q-PCR and D-PCR Devices Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Q-PCR and D-PCR Devices Sales Volume (K Units) by Type (2021-2031)
 Figure 74. South America Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Q-PCR and D-PCR Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Q-PCR and D-PCR Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Q-PCR and D-PCR Devices Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Q-PCR and D-PCR Devices Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Q-PCR and D-PCR Devices Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Q-PCR and D-PCR Devices Revenue (2020-2025) & (US$ Million)
 Figure 81. Q-PCR and D-PCR Devices Industry Chain Mapping
 Figure 82. Regional Q-PCR and D-PCR Devices Manufacturing Base Distribution (%)
 Figure 83. Global Q-PCR and D-PCR Devices Production Market Share by Region (2020-2031)
 Figure 84. Q-PCR and D-PCR Devices Production Process
 Figure 85. Regional Q-PCR and D-PCR Devices Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure